Transparency data

AI task group

Updated 10 January 2024

© Crown copyright 2024

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/uk-national-screening-committee-register-of-interests/ai-task-group

This register records declarations made by members in respect of interests they have that are relevant to the remit of the UK National Screening Committee’s artificial intelligence (AI) task group.

Professor Steve Halligan

None.

Professor Alastair Denniston

  • employer (University Hospitals Birmingham NHSFT) receives significant funding from the industry through its research and development work

Professor Anne-Marie Slowther

  • employed by the University of Warwick who is a founding member of the Alan Turing Institute (national institute for data science and AI) though no direct involvement in AI research

Dr Ben Glocker

  • Kheiron Medical Technologies Ltd (scientific advisor with equity interests)
  • HeartFlow Inc (part-time employment as advisor – medical image analysis)
  • Microsoft Research Ltd (part-time employment as visiting researcher)
  • Imperial College London (primary employer)
  • King’s College London (close collaborator, holding joint research grants)
  • University of Cambridge (close collaborator, holding joint research grants)

Professor Bob Steele

None.

Professor Chris Hyde

  • paid to provide advice to SkinAnalytics, an AI developer for the detection of suspected skin cancer lesions as part of their Clinical Advisory Committee; this includes travel and accommodation expenses to attend meetings at their base in London 1 to 2 times a year
  • academically active and receives research grants to undertake evaluations of tests, including health technology assessments for the UK NSC and NIHR; this currently includes work on AI for diabetic retinopathy screening
  • University of Exeter is an approved supplier who through open competition may be awarded the tender to develop evidence review products for the UK NSC

Dr Kevin Dunbar

None.

Dr Louise Wilkinson

  • member of the Optimam Steering Committee, a collaboration between research scientists at the University of Surrey and CRUK, which amongst other activities is collating a database of mammography imaged to be used for research and evaluation of AI

Dr Peter Garrett

  • registered beneficiary of shares in GSK, AstraZeneca, Smith & Nephew, Royal DutchShell Unilever, Reckitt & Benckiser, and IAG
  • receive royalties as editor of the book ‘Defoaming, Theory and Industrial Applications’ and the author of ‘The Science of Defoaming’; these books contain chapters on the application of antifoams for pharmaceuticals and the medical applications of defoaming
  • visiting academic in the School of Chemical Engineering and Analytical Science, University of Manchester
  • member of the Royal Society of Chemistry and the American Chemical Society
  • member of the Labour Party
  • made written representations about the absence of bowel cancer screening in Wales for the >74year cohort to the Welsh Health Minister via Assembly Member and had interactions with Bowel Cancer UK (Wales) over the matter
  • family member holds a senior position in Smith & Nephew

Dr Ros Given-Wilson

  • clinician working at St Georges breast unit, participating in research projects on AI No financial interest
  • non-executive director Moorfields Eye Hospital, the hospital undertakes AI research No financial interest
  • member of OPTIMAM research group which undertakes research on AI and has developed a database of mammography images funded by CRUK which is provided with open access for research into AI; the group has published on AI and breast imaging and is undertaking AI system validation for NHSX

Dr Sian Taylor-Phillips

  • commissioned by PHE to undertake a rapid review of evidence about breast AI for the UK NSC
  • previously on the advisory group for OPTIMAM (for a period of about 3 months incorporating one meeting); received no reimbursement and no formal links currently
  • employer is the University of Warwick who has some interests in AI
  • the University of Warwick is an approved supplier who through open competition may be awarded the tender to develop evidence review products for the UK NSC
Back to top